Lv1
56 积分 2026-02-10 加入
Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial
4天前
已完结
The effect of overweight and obesity on psoriasis patients in Chinese Han population: a hospital-based study
13天前
已完结
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
14天前
已完结
Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes
15天前
已关闭
Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes
15天前
已完结
Tirzepatide Once Weekly for the Treatment of Obesity
17天前
已完结
Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial
24天前
已完结
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
1个月前
已完结
Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension
1个月前
已完结
Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes
1个月前
已完结
皖公网安备34019202002308
